SlideShare a Scribd company logo
1 of 47
Download to read offline
FORMULATION AND EVALUATION OF FAST
DISSOLVING TABLET
SEMINAR REPORT ON
FAST DISSOLVING TABLET
DOMPERIDONE
BY
PAVULURI RAJA RAJESWARA RAO
MOHAMMED SUFIYAN AHMED
MOHAMMED MUDASSIR
KHAJA FAHEEMUDDIN
MOHAMMED ALTAF ALI
UNDER THE GUIDANCE OF
Mrs. K GOUTHAMI
(Assit. Proff in department of pharmaceutics)
DEPARTMENT OF
PHARMACEUTICS
SHADAN COLLEGE OF PHARMACY
CONTENTS
 INTRODUCTION
 LITERATURE
 OBJECTIVE
 PLAN OF WORK
 DRUG PROFILE
 EXCIPIENT PROFILE
 MATERIALS
 METHODOLOGY
 RESULTS AND DISCUSSION
 CONCLUSION
 REFERENCES
INTRODUCTION
 DEFINATION OF FAST DISSOLVING TABLETS :
A fast disintegrating tablet can be defined as a solid dosage form
that can disintegrate or dissolve within 30 seconds, in the oral
cavity resulting in a solution or suspension without
administration of water.
 REQUIREMENTS OF FAST DISINTEGRATING
TABLET:
 Require no water for oral administration
 Have a pleasing mouth feel.
 Have an acceptable taste masking property.
 Be optimum harder and less friable
 ADVANTAGES :
 Ease of administration to patients who refuse to swallow a
tablet, such as pediatric and geriatric patients and psychiatric
patients.
 No need of water to swallow the dosage form.
 Rapid dissolution and absorption of drug
 Convenience of administration and accurate dosing as
compared to liquids.
 Good mouth feel property helps to change the basic view of
medication as "bitter pill", particularly for pediatric patients.
 DISADVANTAGES:
 The disadvantage of most ODT is that they are fragile
and brittle.
 It needs special package for protection during storage
and transportation.
 CHARACTERISTICS OF FAST DISINTEGRATING
SYSTEMS
a) Ease of administration
b) Taste of the medicament
c) Hygroscopicity
d) Friability
e) Mouth feel
 PREPARATION METHODS OF FAST
DISSOLVING TABLETS
 Freeze drying
 Molding
 Sublimation
 Spray Drying
 Direct Compression
 Melt granulation
 Phase transition process ETC.
S.
NO.
TRADE NAME
ACTIVE
DRUG
MANUFACTURER
1.
Felden fast
melt
Piroxicam Pfiser Inc., NY, USA
2.
Claritin redi
Tab
Loratidine
Schering plough
Corp., USA
3.
Maxalt MLT Rizatriptan
Merck and Co., NJ,
USA
4.
Zyprexia Olanzapine
Eli lilly, Indianapolis,
USA
5.
Pepcid RPD Famotidine
Merck and Co., NJ,
USA
6.
Zofran ODT Ondansetron
Glaxo Wellcome,
Middlesex, UK
7.
Zoming-ZMT Zolmitriptan
AstraZeneca,
Wilmington, USA
8.
Zeplar TM Selegilline
Amarin Corp.,
London, UK
9.
Tempra
Quiclets
Acetaminoph
en
Bristol myers Squibb,
NY, USA
10.
Febrectol Paracetamol
Prographarm,
Chateauneuf, France
List of Marketed Fast Dissolving Tablets
 Mechanism of tablet disintegration:
 Capillary action (Wicking).
 Swelling.
 Due to disintegrating particle/particle repulsive
forces.
 Due to deformation.
 Due to release of gases.
LITERATURE
SURVEY
LITERATURE REVIEW
 Sharma Shailesh*, Singh Gurjeet and Gupta GD.,
developed mouth dissolve tablets of domperidone. Tablet
containing domperidone, camphor and crospovidone were
prepared by direct compression technique.
 Baria A.H et. al
develop a formulation for this drug which overcomes problems
such as difficulty in swallowing, inconvenience in administration
while traveling and better compliance.
 Vikas Sharma, vandana aurora, Chandra ray
developed the fast disintegrating tablets with improved
patient compliance and convenience.
 Himanshu Deshmkh et. al
development of numerous formulations with improved
performance and acceptability.
 SHAILESH SHARMA et. al., (2011)
prepared and evaluated the co processed superdisintegrant in
promoting tablet disintegration and having low friability.
 BIRAJU PATEL et. al., (2009)
fast dissolving tablets of glipizide were prepared by direct
compression method with a view to enhance patient compliance.
Two superdisintegrants via, crospovidone and croscarmellose
sodium (4%, 5%, 6%) with different binders viz, pvp k-30 and
pregelatinized starch (3%) were used.
 P.S.Kawtikwaret et al., (2009)
formulated, evaluated and optimized the fast dissolving tablets
containing tizanidine hydrochloride by using different
superdisintegrants like sodium starch glycolate, croscarmellose
sodium and crospovidone.
OBJECTIVE
OBJECTIVE OF THE STUDY
 The concept of Fast dissolving drug delivery system is to provide
patient with conventional means of taking their medication
 In some cases such as motion sickness, sudden episodes of
allergic attacks or coughing and unavailability of water, swallowing
conventional tablets may be difficult.
 Such problems can be resolved by means of Fast dissolving tablets
when put on tongue these tablets disintegrate and dissolve rapidly in
saliva without need of drinking water.
 Some drugs are absorbed from the mouth, pharynx and esophagus
as saliva passes down into the stomach.
 In such cases, bioavailability of drug is significantly greater than
those observed from conventional tablets dosage form.
PLAN OF
WORK
1. Literature survey
2. Selection of drug and superdisintegrants
3. Determination of analytical methodology for Domperidone
a. Standard graph of Domperidone in 6.8 pH buffer
4. Preformulation studies
5. Preparation of Domperidone fast disintegrating tablets using direct
compression method
6. Evaluation of prepared tablets
a.Weight variation
b.Thickness
c. Hardness
d. Friability
e.Wetting time
f.Water absorption ratio
g. In-vitro disintegration test
h. Content uniformity
i. In-vitro release studies
8. Selection of optimized formulation based on evaluation parameters.
DRUG PROFILE
Name: Domperidone
Description: A specific blocker of dopamine receptors. It speeds
gastrointestinal peristalsis, causes prolactin release,
and is used as antiemetic and tool in the study of
dopaminergic mechanisms.
Structure:
IUPAC Name: 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-1,3-
benzodiazol-1-yl)propyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-
benzodiazol-2-one
Chemical Formula: C22H24ClN5O2
Molecular weight: 425.911
CLINICAL PHARMACOLOGY:
 Domperidone is a D2 dopamine receptor antagonist that blocks the
agonistic action of fescue alkaloids at the cellular level
 does not readily cross the blood-brain barrier
 In humans, domperidone is 91-93% bound to plasma proteins.
 undergoes rapid and extensive hepatic metabolism by hydroxylation
and N-dealkylation.
 Urinary and feacal excretions of domperidone in humans amount 31
and 66% of the oral dose,
 plasma half-life of domperidone administered orally is 6 hours with
low oral bioavailability
Pharmacodynamics:
 a specific blocker of dopamine receptors.
 speeds gastrointestinal peristalsis, causes prolactin release, used as
antiemetic
Mechanism of Action
 Domperidone acts as a gastrointestinal emptying (delayed) adjunct
and peristaltic stimulant.
 decreases small bowel transit time by increasing esophageal and
gastric peristalsis and by lowering esophageal sphincter pressure.
 generally related to its dopamine receptor blocking activity.
 It has strong affinities for the D2 and D3 dopamine
receptors, located just outside the blood brain barrier, that regulates
nausea & vomiting
Indications
 management of dyspepsia, heartburn, epigastric pain, nausea, and
vomiting.
 For oral dosage form (tablets):
 Treatment of GI motility disorder
• Adults—10 mg three to four times daily. Some patients may require
higher doses up to 20 mg three or four times daily.
 Nausea and vomiting:
• Adults—20 (mg) three to four times daily.
Uses of Domperidone :
 increases the contractions of stomach & bowel
 treat nausea and vomiting
 given only by or under the immediate supervision of your doctor.
Storage conditions:
• Store the medicine in a closed container at room temperature, away
from heat, moisture, and direct light. Keep from freezing.
• keep away from children
• don’t keep outdated medicine.
EXCIPIENTS PROFI
Croscarmellose sodium (CCS)
Chemical name: Cellulose, carboxymethyl ether, sodium salt, cross
linked.
Functional category: Tablet and capsule disintegrants
Structural formula:
Molecular weight: 90,000-700,000
Applications in pharmaceutical formulation or
technology:
 used in oral pharmaceutical formulations as a disintegrant
 used in both direct-compression and wet-granulation processes.
Description: odourless, white or grayish white powder.
Solubility: Insoluble in water,soluble in acetone, ethanol , toulene
Uses: used in oral pharmaceutical formulation as a disintegrants
Crospovidone
Chemical Name and CAS Registry Number
1-Ethenyl-2-pyrrolidinone homopolymer [9003-39-8]
Structural Formula
Functional Category : Tablet disintegrant.
Applications in Pharmaceutical Formulation or
Technology
 water-insoluble tablet disintegrant and dissolution agent
 solubility enhancer for poorly soluble drugs
Description: white to creamy-white, finely divided, free-flowing,
tasteless, odorless or nearly odorless, hygroscopic powder.
Stability and Storage Conditions: crospovidone is hygroscopic,
it should be stored in an airtight container in a cool, dry place.
Magnesium stearate
Chemical name: Octadecanoic acid magnesium salt.
Structural formula: [CH3 (CH2)16COO] 2Mg.
Functional category: Tablet and capsule lubricant.
Applications in pharmaceutical formulation or
technology:
 used in cosmetics, foods, and pharmaceutical formulations.
 primarily used as lubricant in tablets and capsule formation.
Description: very fine, light white, precipitated , faint odour of
steric acid & characteristic in taste.
Melting range: 117–1500C (commercial samples), 126–1300C (high
purity magnesium stearate).
Solubility: insoluble in ethanol, ether & slight soluble in warm
benzene
MATERIALS AND
EQUIPMENTS
SISCO
S.
NO
EQUIPMENT NAME
SOURCE
1
DIGITAL WEIGHING
MACHINE
SHIMADZU ATY 244
2
TABLET COMPRESSION
MACHINE
KARNAVATHI
MINI PRESS-I
3
MONSANTO HARDNESS
TESTER
CINTEX IND.
CORPORATION, MUMBAI
4 FRIABILITY TESTER
ELECTROLAB PVT LTD.
INDIA
5
USP DISSOLUTION
APPARATUS
LAB INDIA DS 8000
6
DISINTEGRATION
APPARATUS
LAB INDIA DT 1000
7 TRAY DRYER SISCO
8
UV-VIS DOUBLE BEAM
SPECTROPHOTOMETER
ELICO SL 164DOUBLE
BEAM
SPECTROPHOTOMETER
INSTRUMENTS DETAILS
S.NO DRUG/EXCIPIENTS NAME OF SUPPLIER
1 DOMPERIDONE TORRENT PHARMA
2
LACTOSE MONO
HYDRATE
SD FINE –CHEM PVT, MUMBAI
3 MANNITOL SD-200 SD FINE –CHEM PVT, MUMBAI
4
CROSCARMELLOSE
SODIUM
SD FINE –CHEM PVT, MUMBAI
5 CROSPOVIDON SD FINE –CHEM PVT, MUMBAI
6 ASPERTAME SD FINE –CHEM PVT, MUMBAI
7 MAGNESIUM STEARATE SD FINE –CHEM PVT, MUMBAI
8 TALC SD FINE –CHEM PVT, MUMBAI
INGREDIENT DETAILS
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
Colour, odour, taste and appearance:
The above terms were recorded by using descriptive terminology
Melting point determination:
determined by capillary method by using melting point apparatus
Determination of solubility:
determined by adding excess amount of drug in the solvent and
equilibrium solubility was determined by taking supernatant and
analyzing it on Lab India, double beam spectrophotometer.
% solubility = sample absorbance /standard absorbance × dilution factor
×100
Fourier Transformation Infra-red (FTIR) analysis:
Infra-red spectroscopy analysis was performed by Fourier
Transformation Infrared Spectrophotometer Alpha Brooker FTIR
(Tokyo, Japan).The instrument was calibrated by using polystyrene film.
Ultraviolet Visible (UV-visible) spectroscopy:
Construction of Calibration Curve:
Preparation of Stock Solution: 100 mg of Domperidone was taken in a
100 ml volumetric flask. 5 ml of methanol was added and shaken to
dissolve the drug. Add 7.4 ph phosphate to make upto level.
• From the above solution 1 ml is diluted to 10 ml with, 7.4 pH
phosphate buffer solutions to give 100 µg /ml concentration.
• The prepared solution i.e., 10 µg/ml concentration was scanned for
λmax from 200-400 nm in UV/Visible spectrophotometer.
Evaluation of API and Blend (Pre-compression
Parameters):
Angle of Repose: Flow property was determined by measuring the
Angle of Repose.
Angle of repose= tan-¹ (h/r)
Where, h = height r = radius
Procedure:
• 20gms of the sample was taken
• The sample was passed through the funnel slowly to form a
heap.
• The height of the powder heap formed was measured.
• The circumference formed was drawn with a pencil on the graph
paper . The radius was measured and the angle of repose was
determined. This was repeated three times for a sample.
Bulk density:
Bulk density is ratio of given mass of powder and its bulk volume.
Bulk density = M / V0
Where M= mass of the powder; V0=bulk
volume of the powder.
Tapped density: It is generally given by an equation
Tap density = M / Vr
Where M = mass of the powder,
Vr = final tapping volume of the powder.
Compressibility index and Hausner ratio:
to measure the unsettled apparent volume,(VO), and the final tapped
volume, (Vf), of the powder after tapping the material until no further
volume changes occur. Given by an expression as follows
Compressibility index = 100 × 1-( bulk density /tapped density)
Hausner ratio = tapped density / bulk density
Flow properties determination:
S.No Flow properties Angleof
repose(θ)
Compressibility
Index (%)or Carr’s
index
Hausner ratio
1 Excellent 25-30 <10 1.00-1.11
2 Good 31-35 11-15 1.12-1.18
3 Fair 36-40 16-20 1.19-1.25
4 Passable 41-45 21-25 1.26-1.34
5 Poor 46-55 26-31 1.35-1.45
6 Very poor 56-65 32-37 1.46-1.59
7 Very very poor > 66 >38 >1.6
EVALUATION OF TABLETS (Post Compression
Parameters):
Evaluation include the
diameter, size, shape, thickness, weight, hardness, disintegration &
dissolution characters. Physical Appearance: The general appearance of a tablet.
 Size & Shape: It can be dimensionally described & controlled.
Tablet thickness should be controlled within a ± 5% variation of
standard value.
 Weight variation test: comparison of the weight of the
individual tablets (xi) of a sample of tablets with an upper and lower
percentage limit of the observed sample average (x-mean).
Limits for Tablet Weight variation test:
Average weight of tablet (mg) % Difference allowed
130 or less 10 %
From 130 to 324 7.5 %
> 324 5 %
 Content Uniformity: used to ensure that every tablet contains
the amount of drug substance intended with little variation among
tablets within a batch.
 Friability: The friability test is closely related to tablet hardness &
designed to evaluate the ability of the tablet to withstand abrasion in
packaging, handling & shipping. The percentage friability was
determined by the formula:
% friability = (W1-W2) / W1 X 100
W1 = Weight of tablets before test andW2 = Weight of tablets after test
 Wetting time: time required for water to reach the upper
surface of the tablets was noted as the wetting time.
 Water absorption ratio: A tablet was put on the paper & the
time required for complete wetting was measured.
R = Wa – W b /Wb×100
Where Wa = weight of tablet after absorption
Wb = weight of tablet before absorption
Disintegration time: time required for a tablet to disintegrate.
 Disintegration test : The disintegration test is a measure of the
time required under a given set of conditions for a group of tablets to
disintegrate into particles
 Dissolution study of Domperidone of fast
disintegrating tablets:
Bath temperature : 37  0.5oC
Dissolution media : 7.4 pH buffer
Volume of dissolution media : 900 ml
Aliquot withdrawn : 5 ml
Dissolution apparatus : USP type II (paddle)
Revolutions per minute (Speed) : 50
FORMULATION DEVELOPMENT
List of used Excipients in the formulation:
Ingredients Purpose
Croscarmellose Sodium, Crospovidone Super disintegrants
Lactose monohydrate and Mannitol Diluents
Aspartame Sweetener
Magnesium stearate and Talc Glidant & Lubricant
Procedure for Formulation:
•Weigh all the ingredients (except Mg.Stearate) and sifted through # 44 mesh
separately.
•The ingredients after sifting through sieve no. 44 were thoroughly mixed by
geometrical order and mixed for 10 min.
•And finally add the Glidant (Magnesium Stearate) to the above blend mix it for 2min.
Compressed the above lubricated blend by using 6mm round
punches.
S.NO. Ingredients (mg) F1 F2 F3 F4 F5
1 Domperidone 20 20 20 20 20
2
Croscarmellose
sodium
10 20 10
3 Crospovidon --- --- 10 20 10
4 Lactose anhydrous 122 112 122 112 112
5 Mannitol 40 40 40 40 40
6 Aspertame 3 3 3 3 3
7 Magnesium stearate 3 3 3 3 3
8 Talc 2 2 2 2 2
Total weight(mg) 200 200 200 200 200
Composition of Domperidone Tablets:
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
PREFORMULATION:
S.N
O
API
CHARACTERISATIO
N
RESULTS
1 Physical Appearance Domperidone is a white powder
2 Melting point 242 °C
3 solubility
It is freely soluble in water, soluble in
alcohols, and slightly soluble in
common organic solvents, such as
acetonitrile and methyl ethyl ketone.
4 Bulk density 1.11 gm/ml
5 Tapped Density 1.42 gm/ml
6
Carr’s
index/Compressibility
index
27.92
7 Hausner’s Ratio 1.27
Conclusion:
The value of compressibility index above 25%, 15-25%, less than 15%
indicates poor flowability, optimum flowability & high flowability respectively.
PREPARATION OF STANDARD GRAPH FOR DOMPERIDONE
S. No Concentration (µ/ml) Absorbance (284nm)
1 0 0
2 2 0.072
3 4 0.162
4 6 0.249
5 8 0.329
6 10 0.422
Table for standard graph of domperidone
Standard graph Domperidone
Preformulation studies of blend of all formulation
Formulation
Bulk
density
(gm/cm3)
Tapped
density(gm/cm
3)
Angle of
repose(θ)
Carr’s Index(%) Hausner’s ratio
F1 0.40 0.47 21.5 14.8 1.17
F2 0.41 0.46 20.1 10.86 1.12
F3 0.41 0.47 19.6 12.7 1.14
F4 0.42 0.45 18.8 12.4 1.13
F5 0.43 0.48 17.8 10.4 1.11
FORMULATIO
N CODE
WEIGHT
VARIATIO
N
HARDNES
S
Kg/Cm2
THICKNESS
(mm)
FRIABILIT
Y
(%)
CONTENT
UNIFORMIT
Y
(%)
F1 Passes 4.5 2.08 0.15% 99.2
F2 Passes 5 1.98 0.12% 99.3
F3 Passes 4.3 1.99 0.13% 98.3
F4 Passes 4.4 2.02 0.14% 98.1
F5 Passes 4.8 2.01 0.12% 99.5
EVALUATION STUDIES OF TABLETS:
Disintegration time , Wetting time & Water absorption
ratio of all formulations
Formulation
Disintegration time
(sec)
Wetting time
(sec)
Water Absorption Ratio
F1 21 16 22.95
F2 18 15 24.29
F3 22 18 22.5
F4 20 17 21.5
F5 15 12 24.92
Invitro-Dissolution profiles:
Dissolution media pH 7.4 Phosphate buffer
Volume 900 ml
Apparatus Paddle
Speed 50 rpm
Time 2,4,6,8,10 min
Time
(Min)
F1 F2 F3 F4
F5
0 0 0 0 0 0
2 20.69 22.58 28.14 30.41 36.14
4 27.74 37.11 40.85 44.82 52.95
6 51.01 61.55 65.66 70.41 67.75
8 74.32 80.63 82.17 87.21 91.43
10 85.76 92.58 91.38 94.72 99.80
Dissolution profile of prepared formulations:
Conclusion:
Above graph indicates that %Drug release of F5 formulation shows better drug release when
compared with other formulations.
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
The objective of the present study is to develop a Domperidone
Fast dissolving tablets.
Finally it was concluded that:
Formulation 1&3: Drug and super disintegrant (i.e. Croscarmellose sodium and
Crospovidon) in the ratio of 1:1 which was prepared by direct compression
method have poor wetting property as it consist of less concentration of super
disintegrant.
Formulation 2, 4: consists Drug and superdisintegrants in the ratio of 1:2.
Formulation 5: consists Drug and combination of superdisintegrants in the ratio
of 1:2.
Formulation-5, has shown better dissolution profile and has shown maximum
%drug release within 10 minutes.
Among the all formulations (F1-F5), it was observed that formulation-5
has shown better dissolution profile with sufficient wetting capability. So
Formulation-5 was found to be the best formulation among others.
CONCLUSION
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
• S.S. Biradar, et al., “Fast dissolving drug delivery systems: a brief
overview” , The International Journal of Pharmacology.,2006;4(2).
• M.Slowson , et al ., “What to do when patients cannot swallow their
medications", Pharm. Times ., 1985; 51:90-96
• R.K. chang, et al., “Fast-dissolving tablets”, Pharma Technology.,
2000; 24(6):52-58.
• L.H.Reddy, et al., “Fast dissolving drug delivery systems:A review of
the literature” , International journal of pharmaceutical sciences.July
2002 :331-336.
• N.H. Indurwade , et al., “Novel approach – Fast dissolving tablets” ,
Indian drugs., August 2002; 39(8):405-409. etc
REFERENCES

More Related Content

What's hot

Formulation and Evaluation of Risperidone Fast Dissolving Tablets
Formulation and Evaluation of Risperidone Fast Dissolving TabletsFormulation and Evaluation of Risperidone Fast Dissolving Tablets
Formulation and Evaluation of Risperidone Fast Dissolving TabletsSunil Vadithya
 
Formulation & evaluation of fast dissolving oral film
Formulation & evaluation of fast dissolving oral filmFormulation & evaluation of fast dissolving oral film
Formulation & evaluation of fast dissolving oral filmGaju Shete
 
Challenges in development of orally disintegrating and dispersible tablets
Challenges in development of orally disintegrating and dispersible tabletsChallenges in development of orally disintegrating and dispersible tablets
Challenges in development of orally disintegrating and dispersible tabletsGaurav Kr
 
DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUM
DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUMDESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUM
DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUMReshma Fathima .K
 
Formulation and evaluation of
Formulation and evaluation ofFormulation and evaluation of
Formulation and evaluation ofGajanan Ingole
 
M.Pham project presentation phase 2
M.Pham project presentation phase 2M.Pham project presentation phase 2
M.Pham project presentation phase 2Dhaneshwar P
 
fast disintegrating oral thin films
fast disintegrating oral thin filmsfast disintegrating oral thin films
fast disintegrating oral thin filmssahithi9reddy
 
Orally disintegrating tablets
Orally disintegrating tabletsOrally disintegrating tablets
Orally disintegrating tabletsMd Ali Kadiwala
 
oral controlled drug delivery system
oral controlled drug delivery systemoral controlled drug delivery system
oral controlled drug delivery systemBaliram Musale
 
Modified drug release - Pharmaceutics
Modified drug release - PharmaceuticsModified drug release - Pharmaceutics
Modified drug release - PharmaceuticsAreej Abu Hanieh
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMShiv kumar
 
FORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALFORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALReshma Fathima .K
 

What's hot (20)

Formulation and Evaluation of Risperidone Fast Dissolving Tablets
Formulation and Evaluation of Risperidone Fast Dissolving TabletsFormulation and Evaluation of Risperidone Fast Dissolving Tablets
Formulation and Evaluation of Risperidone Fast Dissolving Tablets
 
Formulation & evaluation of fast dissolving oral film
Formulation & evaluation of fast dissolving oral filmFormulation & evaluation of fast dissolving oral film
Formulation & evaluation of fast dissolving oral film
 
Challenges in development of orally disintegrating and dispersible tablets
Challenges in development of orally disintegrating and dispersible tabletsChallenges in development of orally disintegrating and dispersible tablets
Challenges in development of orally disintegrating and dispersible tablets
 
Tablet ppt
Tablet pptTablet ppt
Tablet ppt
 
DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUM
DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUMDESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUM
DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS OF PANTOPRAZOLE SODIUM
 
Formulation and evaluation of
Formulation and evaluation ofFormulation and evaluation of
Formulation and evaluation of
 
M.Pham project presentation phase 2
M.Pham project presentation phase 2M.Pham project presentation phase 2
M.Pham project presentation phase 2
 
fast disintegrating oral thin films
fast disintegrating oral thin filmsfast disintegrating oral thin films
fast disintegrating oral thin films
 
Orally disintegrating tablets
Orally disintegrating tabletsOrally disintegrating tablets
Orally disintegrating tablets
 
Bilayerd tablets
Bilayerd tabletsBilayerd tablets
Bilayerd tablets
 
Controlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery SystemControlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery System
 
oral controlled drug delivery system
oral controlled drug delivery systemoral controlled drug delivery system
oral controlled drug delivery system
 
Mouth dissolving films
Mouth dissolving filmsMouth dissolving films
Mouth dissolving films
 
Modified drug release - Pharmaceutics
Modified drug release - PharmaceuticsModified drug release - Pharmaceutics
Modified drug release - Pharmaceutics
 
Solid dispersion
Solid dispersionSolid dispersion
Solid dispersion
 
Microspheres
Microspheres Microspheres
Microspheres
 
Parenteral formulations
Parenteral formulationsParenteral formulations
Parenteral formulations
 
Preformulation studies
Preformulation studiesPreformulation studies
Preformulation studies
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEM
 
FORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALFORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUAL
 

Viewers also liked

Competitive Profile Matrix (CPM)
Competitive Profile Matrix (CPM)Competitive Profile Matrix (CPM)
Competitive Profile Matrix (CPM)Sajid Ali
 
Strategy formulation in air asia indonesia strategic management module assi...
Strategy formulation in air asia indonesia   strategic management module assi...Strategy formulation in air asia indonesia   strategic management module assi...
Strategy formulation in air asia indonesia strategic management module assi...Dwitya Aribawa
 
Coca cola company strategies
Coca cola company strategiesCoca cola company strategies
Coca cola company strategiescomsats
 
strategic management of coca cola
strategic management of coca colastrategic management of coca cola
strategic management of coca colaVanita Agrawal
 
strategy formulation vs strategy implementation
strategy formulation vs strategy implementationstrategy formulation vs strategy implementation
strategy formulation vs strategy implementationGeorge V James
 
Strategic formulation
Strategic formulationStrategic formulation
Strategic formulationCesar Rentino
 
strategy formulation
strategy formulationstrategy formulation
strategy formulationMentari Pagi
 
Strategic management project report finallllllllllllllllllll
Strategic management project report finallllllllllllllllllllStrategic management project report finallllllllllllllllllll
Strategic management project report finallllllllllllllllllllsaad ali
 
Strategy Formulation & Implementation
Strategy Formulation & ImplementationStrategy Formulation & Implementation
Strategy Formulation & ImplementationDr. Vickram Aadityaa
 

Viewers also liked (12)

Competitive Profile Matrix (CPM)
Competitive Profile Matrix (CPM)Competitive Profile Matrix (CPM)
Competitive Profile Matrix (CPM)
 
Strategy formulation in air asia indonesia strategic management module assi...
Strategy formulation in air asia indonesia   strategic management module assi...Strategy formulation in air asia indonesia   strategic management module assi...
Strategy formulation in air asia indonesia strategic management module assi...
 
Cpm matrix
Cpm matrixCpm matrix
Cpm matrix
 
Starbucks Competitive Profile Matrix
Starbucks Competitive Profile MatrixStarbucks Competitive Profile Matrix
Starbucks Competitive Profile Matrix
 
Coca cola company strategies
Coca cola company strategiesCoca cola company strategies
Coca cola company strategies
 
strategic management of coca cola
strategic management of coca colastrategic management of coca cola
strategic management of coca cola
 
strategy formulation vs strategy implementation
strategy formulation vs strategy implementationstrategy formulation vs strategy implementation
strategy formulation vs strategy implementation
 
Strategic formulation
Strategic formulationStrategic formulation
Strategic formulation
 
strategy formulation
strategy formulationstrategy formulation
strategy formulation
 
Strategic management project report finallllllllllllllllllll
Strategic management project report finallllllllllllllllllllStrategic management project report finallllllllllllllllllll
Strategic management project report finallllllllllllllllllll
 
Strategy Formulation & Implementation
Strategy Formulation & ImplementationStrategy Formulation & Implementation
Strategy Formulation & Implementation
 
Strategy formulation
Strategy formulationStrategy formulation
Strategy formulation
 

Similar to Formulation and evaluation of fast dissolving tablet- by aryan and rajesh

Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsFormulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsDr. Raghavendra Kumar Gunda
 
Formulation and invitro evaluation of amiodarone orodispersable tablets.
Formulation and invitro evaluation of amiodarone orodispersable tablets.Formulation and invitro evaluation of amiodarone orodispersable tablets.
Formulation and invitro evaluation of amiodarone orodispersable tablets.SriramNagarajan17
 
Formulation and Evaluation of Amlodipine Fast Dissolving Tablets
Formulation and Evaluation of Amlodipine Fast Dissolving TabletsFormulation and Evaluation of Amlodipine Fast Dissolving Tablets
Formulation and Evaluation of Amlodipine Fast Dissolving Tabletsijtsrd
 
Sustained release dds by vidya
Sustained release dds by vidyaSustained release dds by vidya
Sustained release dds by vidyasrividya gorantla
 
Formulation development and invitro evaluation of lamotrigine fast dissolving...
Formulation development and invitro evaluation of lamotrigine fast dissolving...Formulation development and invitro evaluation of lamotrigine fast dissolving...
Formulation development and invitro evaluation of lamotrigine fast dissolving...SriramNagarajan19
 
Oral Dispersible Tablets - A Review
Oral Dispersible Tablets - A ReviewOral Dispersible Tablets - A Review
Oral Dispersible Tablets - A Reviewpharmaindexing
 
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...AkshayAkotkar
 
Challenges in development of orally disintegrating and dispersible
Challenges in development of orally disintegrating and dispersibleChallenges in development of orally disintegrating and dispersible
Challenges in development of orally disintegrating and dispersiblevsrujanav
 
Formulation and evaluation of oral fast dissolving films of project
Formulation and evaluation of oral fast dissolving films of projectFormulation and evaluation of oral fast dissolving films of project
Formulation and evaluation of oral fast dissolving films of projectNikithaGopalpet
 
Modified release drug products
Modified release drug productsModified release drug products
Modified release drug productsSOM NATH PRASAD
 
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...IOSR Journals
 
P.d.d.s. metoprolol succinate
P.d.d.s. metoprolol succinateP.d.d.s. metoprolol succinate
P.d.d.s. metoprolol succinateShilpa Reddy
 
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving TabletsFormulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving TabletsDr. Raghavendra Kumar Gunda
 
roshan 4th seminar word
roshan 4th seminar wordroshan 4th seminar word
roshan 4th seminar wordRoshan Mule
 

Similar to Formulation and evaluation of fast dissolving tablet- by aryan and rajesh (20)

Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsFormulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
 
Formulation and invitro evaluation of amiodarone orodispersable tablets.
Formulation and invitro evaluation of amiodarone orodispersable tablets.Formulation and invitro evaluation of amiodarone orodispersable tablets.
Formulation and invitro evaluation of amiodarone orodispersable tablets.
 
LORNOXICAM
LORNOXICAMLORNOXICAM
LORNOXICAM
 
Shashank Jain
Shashank JainShashank Jain
Shashank Jain
 
INTERNATIONAL INDEXED REFEREED RESEARCH PAPER
INTERNATIONAL INDEXED REFEREED RESEARCH PAPERINTERNATIONAL INDEXED REFEREED RESEARCH PAPER
INTERNATIONAL INDEXED REFEREED RESEARCH PAPER
 
Formulation and Evaluation of Amlodipine Fast Dissolving Tablets
Formulation and Evaluation of Amlodipine Fast Dissolving TabletsFormulation and Evaluation of Amlodipine Fast Dissolving Tablets
Formulation and Evaluation of Amlodipine Fast Dissolving Tablets
 
Sustained release dds by vidya
Sustained release dds by vidyaSustained release dds by vidya
Sustained release dds by vidya
 
Formulation development and invitro evaluation of lamotrigine fast dissolving...
Formulation development and invitro evaluation of lamotrigine fast dissolving...Formulation development and invitro evaluation of lamotrigine fast dissolving...
Formulation development and invitro evaluation of lamotrigine fast dissolving...
 
Oral Dispersible Tablets - A Review
Oral Dispersible Tablets - A ReviewOral Dispersible Tablets - A Review
Oral Dispersible Tablets - A Review
 
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...
 
Challenges in development of orally disintegrating and dispersible
Challenges in development of orally disintegrating and dispersibleChallenges in development of orally disintegrating and dispersible
Challenges in development of orally disintegrating and dispersible
 
Formulation and evaluation of oral fast dissolving films of project
Formulation and evaluation of oral fast dissolving films of projectFormulation and evaluation of oral fast dissolving films of project
Formulation and evaluation of oral fast dissolving films of project
 
Modified release drug products
Modified release drug productsModified release drug products
Modified release drug products
 
Introduction (2)
Introduction (2)Introduction (2)
Introduction (2)
 
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...
 
P.d.d.s. metoprolol succinate
P.d.d.s. metoprolol succinateP.d.d.s. metoprolol succinate
P.d.d.s. metoprolol succinate
 
Orally Disintegrating Strips
Orally Disintegrating Strips Orally Disintegrating Strips
Orally Disintegrating Strips
 
Drug dissolution ppt
Drug dissolution pptDrug dissolution ppt
Drug dissolution ppt
 
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving TabletsFormulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
Formulation Development and Evaluation of Clopidogrel Fast Dissolving Tablets
 
roshan 4th seminar word
roshan 4th seminar wordroshan 4th seminar word
roshan 4th seminar word
 

Recently uploaded

Main Exam Applied biochemistry final year
Main Exam Applied biochemistry final yearMain Exam Applied biochemistry final year
Main Exam Applied biochemistry final yearmarwaahmad357
 
World Water Day 22 March 2024 - kiyorndlab
World Water Day 22 March 2024 - kiyorndlabWorld Water Day 22 March 2024 - kiyorndlab
World Water Day 22 March 2024 - kiyorndlabkiyorndlab
 
Role of herbs in hair care Amla and heena.pptx
Role of herbs in hair care  Amla and  heena.pptxRole of herbs in hair care  Amla and  heena.pptx
Role of herbs in hair care Amla and heena.pptxVaishnaviAware
 
MARKER ASSISTED SELECTION IN CROP IMPROVEMENT
MARKER ASSISTED SELECTION IN CROP IMPROVEMENTMARKER ASSISTED SELECTION IN CROP IMPROVEMENT
MARKER ASSISTED SELECTION IN CROP IMPROVEMENTjipexe1248
 
Alternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabusAlternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabusPradnya Wadekar
 
KeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data scienceKeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data scienceLayne Sadler
 
Krishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्रKrishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्रKrashi Coaching
 
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptxQ3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptxArdeniel
 
Identification of Superclusters and Their Properties in the Sloan Digital Sky...
Identification of Superclusters and Their Properties in the Sloan Digital Sky...Identification of Superclusters and Their Properties in the Sloan Digital Sky...
Identification of Superclusters and Their Properties in the Sloan Digital Sky...Sérgio Sacani
 
Pests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPRPests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPRPirithiRaju
 
Shiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky Way
Shiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky WayShiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky Way
Shiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky WaySérgio Sacani
 
Bureau of Indian Standards Specification of Shampoo.pptx
Bureau of Indian Standards Specification of Shampoo.pptxBureau of Indian Standards Specification of Shampoo.pptx
Bureau of Indian Standards Specification of Shampoo.pptxkastureyashashree
 
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdfPests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdfPirithiRaju
 
Exploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & ResearchExploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & ResearchPrachya Adhyayan
 
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...marwaahmad357
 
Applied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docxApplied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docxmarwaahmad357
 
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...PirithiRaju
 
Gene transfer in plants agrobacterium.pdf
Gene transfer in plants agrobacterium.pdfGene transfer in plants agrobacterium.pdf
Gene transfer in plants agrobacterium.pdfNetHelix
 
Role of Herbs in Cosmetics in Cosmetic Science.
Role of Herbs in Cosmetics in Cosmetic Science.Role of Herbs in Cosmetics in Cosmetic Science.
Role of Herbs in Cosmetics in Cosmetic Science.ShwetaHattimare
 

Recently uploaded (20)

Main Exam Applied biochemistry final year
Main Exam Applied biochemistry final yearMain Exam Applied biochemistry final year
Main Exam Applied biochemistry final year
 
World Water Day 22 March 2024 - kiyorndlab
World Water Day 22 March 2024 - kiyorndlabWorld Water Day 22 March 2024 - kiyorndlab
World Water Day 22 March 2024 - kiyorndlab
 
Role of herbs in hair care Amla and heena.pptx
Role of herbs in hair care  Amla and  heena.pptxRole of herbs in hair care  Amla and  heena.pptx
Role of herbs in hair care Amla and heena.pptx
 
MARKER ASSISTED SELECTION IN CROP IMPROVEMENT
MARKER ASSISTED SELECTION IN CROP IMPROVEMENTMARKER ASSISTED SELECTION IN CROP IMPROVEMENT
MARKER ASSISTED SELECTION IN CROP IMPROVEMENT
 
Alternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabusAlternative system of medicine herbal drug technology syllabus
Alternative system of medicine herbal drug technology syllabus
 
KeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data scienceKeyBio pipeline for bioinformatics and data science
KeyBio pipeline for bioinformatics and data science
 
Krishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्रKrishi Vigyan Kendras - कृषि विज्ञान केंद्र
Krishi Vigyan Kendras - कृषि विज्ञान केंद्र
 
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptxQ3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
Q3W4part1-SSSSSSSSSSSSSSSSSSSSSSSSCI.pptx
 
Identification of Superclusters and Their Properties in the Sloan Digital Sky...
Identification of Superclusters and Their Properties in the Sloan Digital Sky...Identification of Superclusters and Their Properties in the Sloan Digital Sky...
Identification of Superclusters and Their Properties in the Sloan Digital Sky...
 
Pests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPRPests of Redgram_Identification, Binomics_Dr.UPR
Pests of Redgram_Identification, Binomics_Dr.UPR
 
Data delivery from the US-EPA Center for Computational Toxicology and Exposur...
Data delivery from the US-EPA Center for Computational Toxicology and Exposur...Data delivery from the US-EPA Center for Computational Toxicology and Exposur...
Data delivery from the US-EPA Center for Computational Toxicology and Exposur...
 
Shiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky Way
Shiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky WayShiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky Way
Shiva and Shakti: Presumed Proto-Galactic Fragments in the Inner Milky Way
 
Bureau of Indian Standards Specification of Shampoo.pptx
Bureau of Indian Standards Specification of Shampoo.pptxBureau of Indian Standards Specification of Shampoo.pptx
Bureau of Indian Standards Specification of Shampoo.pptx
 
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdfPests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
Pests of cumbu_Identification, Binomics, Integrated ManagementDr.UPR.pdf
 
Exploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & ResearchExploration Method’s in Archaeological Studies & Research
Exploration Method’s in Archaeological Studies & Research
 
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
 
Applied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docxApplied Biochemistry feedback_M Ahwad 2023.docx
Applied Biochemistry feedback_M Ahwad 2023.docx
 
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
3.2 Pests of Sorghum_Identification, Symptoms and nature of damage, Binomics,...
 
Gene transfer in plants agrobacterium.pdf
Gene transfer in plants agrobacterium.pdfGene transfer in plants agrobacterium.pdf
Gene transfer in plants agrobacterium.pdf
 
Role of Herbs in Cosmetics in Cosmetic Science.
Role of Herbs in Cosmetics in Cosmetic Science.Role of Herbs in Cosmetics in Cosmetic Science.
Role of Herbs in Cosmetics in Cosmetic Science.
 

Formulation and evaluation of fast dissolving tablet- by aryan and rajesh

  • 1. FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET
  • 2. SEMINAR REPORT ON FAST DISSOLVING TABLET DOMPERIDONE BY PAVULURI RAJA RAJESWARA RAO MOHAMMED SUFIYAN AHMED MOHAMMED MUDASSIR KHAJA FAHEEMUDDIN MOHAMMED ALTAF ALI UNDER THE GUIDANCE OF Mrs. K GOUTHAMI (Assit. Proff in department of pharmaceutics) DEPARTMENT OF PHARMACEUTICS SHADAN COLLEGE OF PHARMACY
  • 3. CONTENTS  INTRODUCTION  LITERATURE  OBJECTIVE  PLAN OF WORK  DRUG PROFILE  EXCIPIENT PROFILE  MATERIALS  METHODOLOGY  RESULTS AND DISCUSSION  CONCLUSION  REFERENCES
  • 5.  DEFINATION OF FAST DISSOLVING TABLETS : A fast disintegrating tablet can be defined as a solid dosage form that can disintegrate or dissolve within 30 seconds, in the oral cavity resulting in a solution or suspension without administration of water.  REQUIREMENTS OF FAST DISINTEGRATING TABLET:  Require no water for oral administration  Have a pleasing mouth feel.  Have an acceptable taste masking property.  Be optimum harder and less friable
  • 6.  ADVANTAGES :  Ease of administration to patients who refuse to swallow a tablet, such as pediatric and geriatric patients and psychiatric patients.  No need of water to swallow the dosage form.  Rapid dissolution and absorption of drug  Convenience of administration and accurate dosing as compared to liquids.  Good mouth feel property helps to change the basic view of medication as "bitter pill", particularly for pediatric patients.  DISADVANTAGES:  The disadvantage of most ODT is that they are fragile and brittle.  It needs special package for protection during storage and transportation.
  • 7.  CHARACTERISTICS OF FAST DISINTEGRATING SYSTEMS a) Ease of administration b) Taste of the medicament c) Hygroscopicity d) Friability e) Mouth feel  PREPARATION METHODS OF FAST DISSOLVING TABLETS  Freeze drying  Molding  Sublimation  Spray Drying  Direct Compression  Melt granulation  Phase transition process ETC.
  • 8. S. NO. TRADE NAME ACTIVE DRUG MANUFACTURER 1. Felden fast melt Piroxicam Pfiser Inc., NY, USA 2. Claritin redi Tab Loratidine Schering plough Corp., USA 3. Maxalt MLT Rizatriptan Merck and Co., NJ, USA 4. Zyprexia Olanzapine Eli lilly, Indianapolis, USA 5. Pepcid RPD Famotidine Merck and Co., NJ, USA 6. Zofran ODT Ondansetron Glaxo Wellcome, Middlesex, UK 7. Zoming-ZMT Zolmitriptan AstraZeneca, Wilmington, USA 8. Zeplar TM Selegilline Amarin Corp., London, UK 9. Tempra Quiclets Acetaminoph en Bristol myers Squibb, NY, USA 10. Febrectol Paracetamol Prographarm, Chateauneuf, France List of Marketed Fast Dissolving Tablets
  • 9.  Mechanism of tablet disintegration:  Capillary action (Wicking).  Swelling.  Due to disintegrating particle/particle repulsive forces.  Due to deformation.  Due to release of gases.
  • 11. LITERATURE REVIEW  Sharma Shailesh*, Singh Gurjeet and Gupta GD., developed mouth dissolve tablets of domperidone. Tablet containing domperidone, camphor and crospovidone were prepared by direct compression technique.  Baria A.H et. al develop a formulation for this drug which overcomes problems such as difficulty in swallowing, inconvenience in administration while traveling and better compliance.  Vikas Sharma, vandana aurora, Chandra ray developed the fast disintegrating tablets with improved patient compliance and convenience.
  • 12.  Himanshu Deshmkh et. al development of numerous formulations with improved performance and acceptability.  SHAILESH SHARMA et. al., (2011) prepared and evaluated the co processed superdisintegrant in promoting tablet disintegration and having low friability.  BIRAJU PATEL et. al., (2009) fast dissolving tablets of glipizide were prepared by direct compression method with a view to enhance patient compliance. Two superdisintegrants via, crospovidone and croscarmellose sodium (4%, 5%, 6%) with different binders viz, pvp k-30 and pregelatinized starch (3%) were used.  P.S.Kawtikwaret et al., (2009) formulated, evaluated and optimized the fast dissolving tablets containing tizanidine hydrochloride by using different superdisintegrants like sodium starch glycolate, croscarmellose sodium and crospovidone.
  • 14. OBJECTIVE OF THE STUDY  The concept of Fast dissolving drug delivery system is to provide patient with conventional means of taking their medication  In some cases such as motion sickness, sudden episodes of allergic attacks or coughing and unavailability of water, swallowing conventional tablets may be difficult.  Such problems can be resolved by means of Fast dissolving tablets when put on tongue these tablets disintegrate and dissolve rapidly in saliva without need of drinking water.  Some drugs are absorbed from the mouth, pharynx and esophagus as saliva passes down into the stomach.  In such cases, bioavailability of drug is significantly greater than those observed from conventional tablets dosage form.
  • 16. 1. Literature survey 2. Selection of drug and superdisintegrants 3. Determination of analytical methodology for Domperidone a. Standard graph of Domperidone in 6.8 pH buffer 4. Preformulation studies 5. Preparation of Domperidone fast disintegrating tablets using direct compression method 6. Evaluation of prepared tablets a.Weight variation b.Thickness c. Hardness d. Friability e.Wetting time f.Water absorption ratio g. In-vitro disintegration test h. Content uniformity i. In-vitro release studies 8. Selection of optimized formulation based on evaluation parameters.
  • 18. Name: Domperidone Description: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. Structure: IUPAC Name: 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-1,3- benzodiazol-1-yl)propyl]piperidin-4-yl}-2,3-dihydro-1H-1,3- benzodiazol-2-one
  • 19. Chemical Formula: C22H24ClN5O2 Molecular weight: 425.911 CLINICAL PHARMACOLOGY:  Domperidone is a D2 dopamine receptor antagonist that blocks the agonistic action of fescue alkaloids at the cellular level  does not readily cross the blood-brain barrier  In humans, domperidone is 91-93% bound to plasma proteins.  undergoes rapid and extensive hepatic metabolism by hydroxylation and N-dealkylation.  Urinary and feacal excretions of domperidone in humans amount 31 and 66% of the oral dose,  plasma half-life of domperidone administered orally is 6 hours with low oral bioavailability Pharmacodynamics:  a specific blocker of dopamine receptors.  speeds gastrointestinal peristalsis, causes prolactin release, used as antiemetic
  • 20. Mechanism of Action  Domperidone acts as a gastrointestinal emptying (delayed) adjunct and peristaltic stimulant.  decreases small bowel transit time by increasing esophageal and gastric peristalsis and by lowering esophageal sphincter pressure.  generally related to its dopamine receptor blocking activity.  It has strong affinities for the D2 and D3 dopamine receptors, located just outside the blood brain barrier, that regulates nausea & vomiting Indications  management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.  For oral dosage form (tablets):  Treatment of GI motility disorder • Adults—10 mg three to four times daily. Some patients may require higher doses up to 20 mg three or four times daily.  Nausea and vomiting: • Adults—20 (mg) three to four times daily.
  • 21. Uses of Domperidone :  increases the contractions of stomach & bowel  treat nausea and vomiting  given only by or under the immediate supervision of your doctor. Storage conditions: • Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing. • keep away from children • don’t keep outdated medicine.
  • 23. Croscarmellose sodium (CCS) Chemical name: Cellulose, carboxymethyl ether, sodium salt, cross linked. Functional category: Tablet and capsule disintegrants Structural formula: Molecular weight: 90,000-700,000 Applications in pharmaceutical formulation or technology:  used in oral pharmaceutical formulations as a disintegrant  used in both direct-compression and wet-granulation processes. Description: odourless, white or grayish white powder. Solubility: Insoluble in water,soluble in acetone, ethanol , toulene Uses: used in oral pharmaceutical formulation as a disintegrants
  • 24. Crospovidone Chemical Name and CAS Registry Number 1-Ethenyl-2-pyrrolidinone homopolymer [9003-39-8] Structural Formula Functional Category : Tablet disintegrant. Applications in Pharmaceutical Formulation or Technology  water-insoluble tablet disintegrant and dissolution agent  solubility enhancer for poorly soluble drugs Description: white to creamy-white, finely divided, free-flowing, tasteless, odorless or nearly odorless, hygroscopic powder. Stability and Storage Conditions: crospovidone is hygroscopic, it should be stored in an airtight container in a cool, dry place.
  • 25. Magnesium stearate Chemical name: Octadecanoic acid magnesium salt. Structural formula: [CH3 (CH2)16COO] 2Mg. Functional category: Tablet and capsule lubricant. Applications in pharmaceutical formulation or technology:  used in cosmetics, foods, and pharmaceutical formulations.  primarily used as lubricant in tablets and capsule formation. Description: very fine, light white, precipitated , faint odour of steric acid & characteristic in taste. Melting range: 117–1500C (commercial samples), 126–1300C (high purity magnesium stearate). Solubility: insoluble in ethanol, ether & slight soluble in warm benzene
  • 27. S. NO EQUIPMENT NAME SOURCE 1 DIGITAL WEIGHING MACHINE SHIMADZU ATY 244 2 TABLET COMPRESSION MACHINE KARNAVATHI MINI PRESS-I 3 MONSANTO HARDNESS TESTER CINTEX IND. CORPORATION, MUMBAI 4 FRIABILITY TESTER ELECTROLAB PVT LTD. INDIA 5 USP DISSOLUTION APPARATUS LAB INDIA DS 8000 6 DISINTEGRATION APPARATUS LAB INDIA DT 1000 7 TRAY DRYER SISCO 8 UV-VIS DOUBLE BEAM SPECTROPHOTOMETER ELICO SL 164DOUBLE BEAM SPECTROPHOTOMETER INSTRUMENTS DETAILS
  • 28. S.NO DRUG/EXCIPIENTS NAME OF SUPPLIER 1 DOMPERIDONE TORRENT PHARMA 2 LACTOSE MONO HYDRATE SD FINE –CHEM PVT, MUMBAI 3 MANNITOL SD-200 SD FINE –CHEM PVT, MUMBAI 4 CROSCARMELLOSE SODIUM SD FINE –CHEM PVT, MUMBAI 5 CROSPOVIDON SD FINE –CHEM PVT, MUMBAI 6 ASPERTAME SD FINE –CHEM PVT, MUMBAI 7 MAGNESIUM STEARATE SD FINE –CHEM PVT, MUMBAI 8 TALC SD FINE –CHEM PVT, MUMBAI INGREDIENT DETAILS
  • 30. Colour, odour, taste and appearance: The above terms were recorded by using descriptive terminology Melting point determination: determined by capillary method by using melting point apparatus Determination of solubility: determined by adding excess amount of drug in the solvent and equilibrium solubility was determined by taking supernatant and analyzing it on Lab India, double beam spectrophotometer. % solubility = sample absorbance /standard absorbance × dilution factor ×100 Fourier Transformation Infra-red (FTIR) analysis: Infra-red spectroscopy analysis was performed by Fourier Transformation Infrared Spectrophotometer Alpha Brooker FTIR (Tokyo, Japan).The instrument was calibrated by using polystyrene film.
  • 31. Ultraviolet Visible (UV-visible) spectroscopy: Construction of Calibration Curve: Preparation of Stock Solution: 100 mg of Domperidone was taken in a 100 ml volumetric flask. 5 ml of methanol was added and shaken to dissolve the drug. Add 7.4 ph phosphate to make upto level. • From the above solution 1 ml is diluted to 10 ml with, 7.4 pH phosphate buffer solutions to give 100 µg /ml concentration. • The prepared solution i.e., 10 µg/ml concentration was scanned for λmax from 200-400 nm in UV/Visible spectrophotometer. Evaluation of API and Blend (Pre-compression Parameters): Angle of Repose: Flow property was determined by measuring the Angle of Repose. Angle of repose= tan-¹ (h/r) Where, h = height r = radius
  • 32. Procedure: • 20gms of the sample was taken • The sample was passed through the funnel slowly to form a heap. • The height of the powder heap formed was measured. • The circumference formed was drawn with a pencil on the graph paper . The radius was measured and the angle of repose was determined. This was repeated three times for a sample. Bulk density: Bulk density is ratio of given mass of powder and its bulk volume. Bulk density = M / V0 Where M= mass of the powder; V0=bulk volume of the powder. Tapped density: It is generally given by an equation Tap density = M / Vr Where M = mass of the powder, Vr = final tapping volume of the powder.
  • 33. Compressibility index and Hausner ratio: to measure the unsettled apparent volume,(VO), and the final tapped volume, (Vf), of the powder after tapping the material until no further volume changes occur. Given by an expression as follows Compressibility index = 100 × 1-( bulk density /tapped density) Hausner ratio = tapped density / bulk density Flow properties determination: S.No Flow properties Angleof repose(θ) Compressibility Index (%)or Carr’s index Hausner ratio 1 Excellent 25-30 <10 1.00-1.11 2 Good 31-35 11-15 1.12-1.18 3 Fair 36-40 16-20 1.19-1.25 4 Passable 41-45 21-25 1.26-1.34 5 Poor 46-55 26-31 1.35-1.45 6 Very poor 56-65 32-37 1.46-1.59 7 Very very poor > 66 >38 >1.6
  • 34. EVALUATION OF TABLETS (Post Compression Parameters): Evaluation include the diameter, size, shape, thickness, weight, hardness, disintegration & dissolution characters. Physical Appearance: The general appearance of a tablet.  Size & Shape: It can be dimensionally described & controlled. Tablet thickness should be controlled within a ± 5% variation of standard value.  Weight variation test: comparison of the weight of the individual tablets (xi) of a sample of tablets with an upper and lower percentage limit of the observed sample average (x-mean). Limits for Tablet Weight variation test: Average weight of tablet (mg) % Difference allowed 130 or less 10 % From 130 to 324 7.5 % > 324 5 %  Content Uniformity: used to ensure that every tablet contains the amount of drug substance intended with little variation among tablets within a batch.
  • 35.  Friability: The friability test is closely related to tablet hardness & designed to evaluate the ability of the tablet to withstand abrasion in packaging, handling & shipping. The percentage friability was determined by the formula: % friability = (W1-W2) / W1 X 100 W1 = Weight of tablets before test andW2 = Weight of tablets after test  Wetting time: time required for water to reach the upper surface of the tablets was noted as the wetting time.  Water absorption ratio: A tablet was put on the paper & the time required for complete wetting was measured. R = Wa – W b /Wb×100 Where Wa = weight of tablet after absorption Wb = weight of tablet before absorption Disintegration time: time required for a tablet to disintegrate.  Disintegration test : The disintegration test is a measure of the time required under a given set of conditions for a group of tablets to disintegrate into particles
  • 36.  Dissolution study of Domperidone of fast disintegrating tablets: Bath temperature : 37  0.5oC Dissolution media : 7.4 pH buffer Volume of dissolution media : 900 ml Aliquot withdrawn : 5 ml Dissolution apparatus : USP type II (paddle) Revolutions per minute (Speed) : 50 FORMULATION DEVELOPMENT List of used Excipients in the formulation: Ingredients Purpose Croscarmellose Sodium, Crospovidone Super disintegrants Lactose monohydrate and Mannitol Diluents Aspartame Sweetener Magnesium stearate and Talc Glidant & Lubricant
  • 37. Procedure for Formulation: •Weigh all the ingredients (except Mg.Stearate) and sifted through # 44 mesh separately. •The ingredients after sifting through sieve no. 44 were thoroughly mixed by geometrical order and mixed for 10 min. •And finally add the Glidant (Magnesium Stearate) to the above blend mix it for 2min. Compressed the above lubricated blend by using 6mm round punches. S.NO. Ingredients (mg) F1 F2 F3 F4 F5 1 Domperidone 20 20 20 20 20 2 Croscarmellose sodium 10 20 10 3 Crospovidon --- --- 10 20 10 4 Lactose anhydrous 122 112 122 112 112 5 Mannitol 40 40 40 40 40 6 Aspertame 3 3 3 3 3 7 Magnesium stearate 3 3 3 3 3 8 Talc 2 2 2 2 2 Total weight(mg) 200 200 200 200 200 Composition of Domperidone Tablets:
  • 39. PREFORMULATION: S.N O API CHARACTERISATIO N RESULTS 1 Physical Appearance Domperidone is a white powder 2 Melting point 242 °C 3 solubility It is freely soluble in water, soluble in alcohols, and slightly soluble in common organic solvents, such as acetonitrile and methyl ethyl ketone. 4 Bulk density 1.11 gm/ml 5 Tapped Density 1.42 gm/ml 6 Carr’s index/Compressibility index 27.92 7 Hausner’s Ratio 1.27 Conclusion: The value of compressibility index above 25%, 15-25%, less than 15% indicates poor flowability, optimum flowability & high flowability respectively.
  • 40. PREPARATION OF STANDARD GRAPH FOR DOMPERIDONE S. No Concentration (µ/ml) Absorbance (284nm) 1 0 0 2 2 0.072 3 4 0.162 4 6 0.249 5 8 0.329 6 10 0.422 Table for standard graph of domperidone Standard graph Domperidone
  • 41. Preformulation studies of blend of all formulation Formulation Bulk density (gm/cm3) Tapped density(gm/cm 3) Angle of repose(θ) Carr’s Index(%) Hausner’s ratio F1 0.40 0.47 21.5 14.8 1.17 F2 0.41 0.46 20.1 10.86 1.12 F3 0.41 0.47 19.6 12.7 1.14 F4 0.42 0.45 18.8 12.4 1.13 F5 0.43 0.48 17.8 10.4 1.11 FORMULATIO N CODE WEIGHT VARIATIO N HARDNES S Kg/Cm2 THICKNESS (mm) FRIABILIT Y (%) CONTENT UNIFORMIT Y (%) F1 Passes 4.5 2.08 0.15% 99.2 F2 Passes 5 1.98 0.12% 99.3 F3 Passes 4.3 1.99 0.13% 98.3 F4 Passes 4.4 2.02 0.14% 98.1 F5 Passes 4.8 2.01 0.12% 99.5 EVALUATION STUDIES OF TABLETS:
  • 42. Disintegration time , Wetting time & Water absorption ratio of all formulations Formulation Disintegration time (sec) Wetting time (sec) Water Absorption Ratio F1 21 16 22.95 F2 18 15 24.29 F3 22 18 22.5 F4 20 17 21.5 F5 15 12 24.92 Invitro-Dissolution profiles: Dissolution media pH 7.4 Phosphate buffer Volume 900 ml Apparatus Paddle Speed 50 rpm Time 2,4,6,8,10 min
  • 43. Time (Min) F1 F2 F3 F4 F5 0 0 0 0 0 0 2 20.69 22.58 28.14 30.41 36.14 4 27.74 37.11 40.85 44.82 52.95 6 51.01 61.55 65.66 70.41 67.75 8 74.32 80.63 82.17 87.21 91.43 10 85.76 92.58 91.38 94.72 99.80 Dissolution profile of prepared formulations: Conclusion: Above graph indicates that %Drug release of F5 formulation shows better drug release when compared with other formulations.
  • 45. The objective of the present study is to develop a Domperidone Fast dissolving tablets. Finally it was concluded that: Formulation 1&3: Drug and super disintegrant (i.e. Croscarmellose sodium and Crospovidon) in the ratio of 1:1 which was prepared by direct compression method have poor wetting property as it consist of less concentration of super disintegrant. Formulation 2, 4: consists Drug and superdisintegrants in the ratio of 1:2. Formulation 5: consists Drug and combination of superdisintegrants in the ratio of 1:2. Formulation-5, has shown better dissolution profile and has shown maximum %drug release within 10 minutes. Among the all formulations (F1-F5), it was observed that formulation-5 has shown better dissolution profile with sufficient wetting capability. So Formulation-5 was found to be the best formulation among others. CONCLUSION
  • 47. • S.S. Biradar, et al., “Fast dissolving drug delivery systems: a brief overview” , The International Journal of Pharmacology.,2006;4(2). • M.Slowson , et al ., “What to do when patients cannot swallow their medications", Pharm. Times ., 1985; 51:90-96 • R.K. chang, et al., “Fast-dissolving tablets”, Pharma Technology., 2000; 24(6):52-58. • L.H.Reddy, et al., “Fast dissolving drug delivery systems:A review of the literature” , International journal of pharmaceutical sciences.July 2002 :331-336. • N.H. Indurwade , et al., “Novel approach – Fast dissolving tablets” , Indian drugs., August 2002; 39(8):405-409. etc REFERENCES